EA did announce that The Veilguard underperformed, even if expectations were perhaps set a little too high, but blaming this ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Gain’s lead program in Parkinson’s disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, ...

Kate Stratten leads Chapel Hill's IntraHealth International as it faces challenges in the wake of the Trump administration’s ...